UBS AM’s Dyne Therapeutics DYN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.8M | Buy |
293,644
+135,853
| +86% | +$1.29M | ﹤0.01% | 1992 |
|
|
2025
Q1 | $1.65M | Buy |
157,791
+14,428
| +10% | +$151K | ﹤0.01% | 2083 |
|
|
2024
Q4 | $3.38M | Buy |
143,363
+9,029
| +7% | +$213K | ﹤0.01% | 1793 |
|
|
2024
Q3 | $4.83M | Buy |
134,334
+6,784
| +5% | +$244K | ﹤0.01% | 1590 |
|
|
2024
Q2 | $4.5M | Buy |
127,550
+96,269
| +308% | +$3.4M | ﹤0.01% | 1548 |
|
|
2024
Q1 | $888K | Buy |
31,281
+5,892
| +23% | +$167K | ﹤0.01% | 2072 |
|
|
2023
Q4 | $338K | Buy |
25,389
+13,167
| +108% | +$175K | ﹤0.01% | 2400 |
|
|
2023
Q3 | $110K | Hold |
12,222
| – | – | ﹤0.01% | 2559 |
|
|
2023
Q2 | $141K | Hold |
12,222
| – | – | ﹤0.01% | 2610 |
|
|
2023
Q1 | $141K | Hold |
12,222
| – | – | ﹤0.01% | 2610 |
|
|
2022
Q4 | $142K | Hold |
12,222
| – | – | ﹤0.01% | 2478 |
|
|
2022
Q3 | $155K | Hold |
12,222
| – | – | ﹤0.01% | 2644 |
|
|
2022
Q2 | $84K | Hold |
12,222
| – | – | ﹤0.01% | 2658 |
|
|
2022
Q1 | $118K | Hold |
12,222
| – | – | ﹤0.01% | 2728 |
|
|
2021
Q4 | $145K | Hold |
12,222
| – | – | ﹤0.01% | 2794 |
|
|
2021
Q3 | $198K | Buy |
+12,222
| New | +$198K | ﹤0.01% | 2694 |
|